[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ticker Wire [@Tickerwire](/creator/twitter/Tickerwire) on x XXX followers Created: 2025-07-25 12:41:16 UTC In premarket trading, $ABSI Absci Corp sinks XX% after pricing a $50M stock offering. $CNC Centene plunges XX% on a surprise Q2 loss of $XXXX and pulls full-year guidance. $SRPT Sarepta Therapeutics drops XX% after Brazil suspends use of its gene therapy Elevidys. XXXXX engagements  **Related Topics** [cnc](/topic/cnc) [50m](/topic/50m) [eps](/topic/eps) [losses](/topic/losses) [brazil](/topic/brazil) [drops](/topic/drops) [$srpt](/topic/$srpt) [$50m](/topic/$50m) [Post Link](https://x.com/Tickerwire/status/1948725234682790387)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ticker Wire @Tickerwire on x XXX followers
Created: 2025-07-25 12:41:16 UTC
In premarket trading, $ABSI Absci Corp sinks XX% after pricing a $50M stock offering.
$CNC Centene plunges XX% on a surprise Q2 loss of $XXXX and pulls full-year guidance.
$SRPT Sarepta Therapeutics drops XX% after Brazil suspends use of its gene therapy Elevidys.
XXXXX engagements
/post/tweet::1948725234682790387